PubPeer
The online Journal club
login
create account
Home
Publications
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Breast Cancer Research and Treatment (2012) -
Comments
pubmed: 22562176 doi: 10.1007/s10549-012-2079-4 issn: 0167-6806 issn: 1573-7217
Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan
Go to article
Go to preprint
Springer Science and Business Media LLC
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})